Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study

PHASE4CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

May 17, 2021

Primary Completion Date

September 19, 2022

Study Completion Date

September 19, 2022

Conditions
Excessive Daytime SleepinessObstructive Sleep ApneaImpaired Cognitive Function
Interventions
DRUG

Solriamfetol

Solriamfetol 75 mg/d Solriamfetol 150 mg/d

DRUG

Placebo

Placebo

Trial Locations (28)

20132

IRCCS Ospedale San Raffaele - Servizio Farmacia, Milan

20815

The Center for Sleep & Wake Disorders, Chevy Chase

25198

Instiut de Reccerca Biomedica de Lledia, Lleida

28078

Advanced Respiratory and Sleep Medicine, PLLC, Huntersville

29201

Bogan Sleep Consultants, LLC, Columbia

30328

NeuroTrials Research Inc, Atlanta

30501

The Neurological Center of north Georgia., Gainesville

32256

Clinical Neuroscience Solutions, Inc, Jacksonville

40139

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna

45212

CTI-Clinical Research Center, Cincinnati

45245

Intrepid Research, LLC, Cincinnati

48377

Henry Ford Health System, Novi

56126

UOC Farmacia e Politiche del farmaco, edif 41, Pisa

63017

Sleep Medicine & Research Center, Chesterfield

78229

Sleep Therapy & Research Center, San Antonio

78731

FutureSearch Trials of Neuroglogy, Austin

90048

Southern California Institute for Respiratory Disease, Los Angeles

92705

SDS Clinical Trials, Inc, Santa Ana

94018

IRCCS Associazione Oasi Maria SS Onlus, Troina

99202

Sleep and Performance Research Center, Spokane

T2N 4N1

University of Calgary, Calgary

M4P 1P2

MedSleep Inc. o/a Toronto Sleep Institute, Toronto

M5S 3A3

Jodha Tishon Inc, Toronto

4818 CK

Amphia Hospital, Breda

2104 SW

Sleep-Waakcentrum SEIN, Heemstede

08036

Hospital Clinic de Barcelona, Barcelona

08041

Hospital de la Santa Creu I Sant Pau, Barcelona

CB23 3RE

Royal Papworh Hospital, Cambridge

Sponsors
All Listed Sponsors
lead

Axsome Therapeutics, Inc.

INDUSTRY

NCT04789174 - Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study | Biotech Hunter | Biotech Hunter